Captrust Financial Advisors Celldex Therapeutics, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$20.5 - $37.33 $656 - $1,194	-32 Reduced 4.92%	618 $17,000
Q2 2022 Aug 16, 2022	BUY	$20.5 - $37.33 $12,423 - $22,621	606 Added 1377.27%	650 $18,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $1,990 - $2,831	-72 Reduced 62.07%	44 $1,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $53,734 - $84,742	-1,506 Reduced 92.85%	116 $4,000
Q3 2021 Nov 16, 2021	BUY	$28.95 - $55.99 $46,956 - $90,815	1,622 New	1,622 $88,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.